Pezzuto JM - Search Results

1

Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent.

Gerhauser C, Lee SK, Kosmeder JW, Moriarty RM, Hamel E, Mehta RG, Moon RC, Pezzuto JM. Gerhauser C, et al. Among authors: pezzuto jm. Cancer Res. 1997 Aug 15;57(16):3429-35. Cancer Res. 1997. PMID: 9270009

2

Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice.

Murillo G, Kosmeder JW 2nd, Pezzuto JM, Mehta RG. Murillo G, et al. Among authors: pezzuto jm. Int J Cancer. 2003 Mar 10;104(1):7-11. doi: 10.1002/ijc.10901. Int J Cancer. 2003. PMID: 12532413

3

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.

Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Jang M, et al. Among authors: pezzuto jm. Science. 1997 Jan 10;275(5297):218-20. doi: 10.1126/science.275.5297.218. Science. 1997. PMID: 8985016

4

Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes.

Gerhäuser C, You M, Liu J, Moriarty RM, Hawthorne M, Mehta RG, Moon RC, Pezzuto JM. Gerhäuser C, et al. Among authors: pezzuto jm. Cancer Res. 1997 Jan 15;57(2):272-8. Cancer Res. 1997. PMID: 9000567

5

Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid.

Udeani GO, Gerhauser C, Thomas CF, Moon RC, Kosmeder JW, Kinghorn AD, Moriarty RM, Pezzuto JM. Udeani GO, et al. Among authors: pezzuto jm. Cancer Res. 1997 Aug 15;57(16):3424-8. Cancer Res. 1997. PMID: 9270008

6

Cancer chemopreventive activity mediated by 4'-bromoflavone, a potent inducer of phase II detoxification enzymes.

Song LL, Kosmeder JW 2nd, Lee SK, Gerhäuser C, Lantvit D, Moon RC, Moriarty RM, Pezzuto JM. Song LL, et al. Among authors: pezzuto jm. Cancer Res. 1999 Feb 1;59(3):578-85. Cancer Res. 1999. PMID: 9973203

7

Inhibitory effect of munetone, an isoflavonoid, on 12-O-tetradecanoylphorbol 13-acetate-induced ornithine decarboxylase activity.

Lee SK, Luyengi L, Gerhäuser C, Mar W, Lee K, Mehta RG, Kinghorn AD, Pezzuto JM. Lee SK, et al. Among authors: pezzuto jm. Cancer Lett. 1999 Feb 8;136(1):59-65. doi: 10.1016/s0304-3835(98)00309-7. Cancer Lett. 1999. PMID: 10211940

8

Evaluation of the potential of cancer chemopreventive activity mediated by inhibition of 12-O-tetradecanoyl phorbol 13-acetate-induced ornithine decarboxylase activity.

Lee SK, Pezzuto JM. Lee SK, et al. Among authors: pezzuto jm. Arch Pharm Res. 1999 Dec;22(6):559-64. doi: 10.1007/BF02975326. Arch Pharm Res. 1999. PMID: 10615860

9

Intermediate biomarkers.

Kosmeder JW 2nd, Pezzuto JM. Kosmeder JW 2nd, et al. Among authors: pezzuto jm. Cancer Treat Res. 2001;106:31-61. doi: 10.1007/978-1-4615-1657-6_2. Cancer Treat Res. 2001. PMID: 11225008 Review. No abstract available.

10

Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats.

Udeani GO, Zhao GM, Shin YG, Kosmeder JW 2nd, Beecher CW, Kinghorn AD, Moriarty RM, Moon RC, Pezzuto JM. Udeani GO, et al. Among authors: pezzuto jm. Cancer Chemother Pharmacol. 2001 Mar;47(3):263-8. doi: 10.1007/s002800000187. Cancer Chemother Pharmacol. 2001. PMID: 11320671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters